Nautilus Biotechnology In...

NASDAQ: NAUT · Real-Time Price · USD
0.71
-0.01 (-1.63%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.18%
After-hours: Aug 15, 2025, 04:32 PM EDT

Nautilus Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 5.71M 3.42M n/a
Gross Profit
n/a -5.71M -3.42M -2.84M
Operating Income
-81.48M -76.15M -63.62M -50.5M
Interest Income
10.78M 12.55M 5.82M 329K
Pretax Income
-70.78M -63.67M -57.92M -50.31M
Net Income
-70.78M -63.67M -57.92M -50.31M
Selling & General & Admin
31M 28.9M 25.95M 21.15M
Research & Development
50.48M 47.25M 37.67M 29.35M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
81.48M 76.15M 63.62M 50.5M
Interest Expense
n/a n/a 5.82M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 76.15M 63.62M 50.5M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
125.43M 124.92M 124.59M 84.46M
Shares Outstanding (Diluted)
125.43M 124.92M 124.59M 84.46M
EPS (Basic)
-0.56 -0.51 -0.46 -0.6
EPS (Diluted)
-0.56 -0.51 -0.46 -0.6
EBITDA
-64.43M -74.3M -60.2M -47.66M
EBIT
-70.78M -76.15M -63.62M -50.5M
Depreciation & Amortization
6.35M 1.85M 3.42M 2.84M